SaerogenBio Overview

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 2

SaerogenBio General Information

Description

Operator of a bio-venture company intended for drug discovery and development. The company builds a pipeline of novel therapeutics, including anticancer drugs and treatments for degenerative brain diseases, and concentrates on developing medicines for intractable and unmet medical needs, enabling the healthcare industry to accelerate candidate substance development and bring new drugs close to commercialization.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Seoul, Gangnam-gu
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Seoul, Gangnam-gu
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SaerogenBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Jan-2026 Completed Startup
1. Accelerator/Incubator Completed Startup
To view SaerogenBio’s complete valuation and funding history, request access »

SaerogenBio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mirae Science and Technology Venture Capital Minority
Myriad Life Sciences Accelerator/Incubator Minority
To view SaerogenBio’s complete investors history, request access »

Ready to get started?

Request a free trial

SaerogenBio FAQs

  • Where is SaerogenBio headquartered?

    SaerogenBio is headquartered in Seoul, South Korea.

  • What industry is SaerogenBio in?

    SaerogenBio’s primary industry is Drug Discovery.

  • Is SaerogenBio a private or public company?

    SaerogenBio is a Private company.

  • What is SaerogenBio’s current revenue?

    The current revenue for SaerogenBio is .

  • Who are SaerogenBio’s investors?

    Mirae Science and Technology and Myriad Life Sciences have invested in SaerogenBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process